Genes Tech Group Holdings Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Genes Tech Group Holdings heeft een totaal eigen vermogen van NT$836.9M en een totale schuld van NT$620.2M, wat de schuld-eigenvermogensverhouding op 74.1% brengt. De totale activa en totale passiva bedragen respectievelijk NT$2.2B en NT$1.3B. De EBIT Genes Tech Group Holdings is NT$80.8M waardoor de rentedekking 4.4 is. Het heeft contanten en kortetermijnbeleggingen van NT$119.1M.
Belangrijke informatie
74.1%
Verhouding schuld/eigen vermogen
NT$620.20m
Schuld
| Rente dekkingsratio | 4.4x |
| Contant | NT$119.08m |
| Aandelen | NT$836.91m |
| Totaal verplichtingen | NT$1.33b |
| Totaal activa | NT$2.16b |
Recente financiële gezondheidsupdates
Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Aug 20
Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Sep 08Does Genes Tech Group Holdings (HKG:8257) Have A Healthy Balance Sheet?
May 19These 4 Measures Indicate That Genes Tech Group Holdings (HKG:8257) Is Using Debt Extensively
Oct 21Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Apr 13Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Nov 26Recent updates
Why Investors Shouldn't Be Surprised By Genes Tech Group Holdings Company Limited's (HKG:8257) 32% Share Price Plunge
Nov 20Genes Tech Group Holdings (HKG:8257) Could Be Struggling To Allocate Capital
Nov 14Lacklustre Performance Is Driving Genes Tech Group Holdings Company Limited's (HKG:8257) Low P/S
Oct 03Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Aug 20Genes Tech Group Holdings (HKG:8257) Has More To Do To Multiply In Value Going Forward
Jun 05There's No Escaping Genes Tech Group Holdings Company Limited's (HKG:8257) Muted Revenues Despite A 27% Share Price Rise
Jun 05Improved Revenues Required Before Genes Tech Group Holdings Company Limited (HKG:8257) Stock's 37% Jump Looks Justified
Apr 17Returns On Capital Are Showing Encouraging Signs At Genes Tech Group Holdings (HKG:8257)
Feb 22Improved Revenues Required Before Genes Tech Group Holdings Company Limited (HKG:8257) Shares Find Their Feet
Dec 20Why We Like The Returns At Genes Tech Group Holdings (HKG:8257)
Oct 19Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Sep 08Returns On Capital Are A Standout For Genes Tech Group Holdings (HKG:8257)
Jul 11Does Genes Tech Group Holdings (HKG:8257) Have A Healthy Balance Sheet?
May 19Calculating The Fair Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Mar 01Genes Tech Group Holdings (HKG:8257) Might Be Having Difficulty Using Its Capital Effectively
Dec 27Estimating The Intrinsic Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Nov 30These 4 Measures Indicate That Genes Tech Group Holdings (HKG:8257) Is Using Debt Extensively
Oct 21Returns On Capital At Genes Tech Group Holdings (HKG:8257) Paint A Concerning Picture
Sep 06Genes Tech Group Holdings' (HKG:8257) Returns On Capital Not Reflecting Well On The Business
May 26Is Genes Tech Group Holdings (HKG:8257) A Risky Investment?
Apr 13Genes Tech Group Holdings (HKG:8257) Has Some Way To Go To Become A Multi-Bagger
Feb 09Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Nov 26We Think Shareholders Will Probably Be Generous With Genes Tech Group Holdings Company Limited's (HKG:8257) CEO Compensation
Jun 18Returns On Capital At Genes Tech Group Holdings (HKG:8257) Have Stalled
May 26Why Genes Tech Group Holdings Company Limited (HKG:8257) Is A Dividend Rockstar
Apr 08Genes Tech Group Holdings (HKG:8257) Has A Somewhat Strained Balance Sheet
Mar 18Returns On Capital - An Important Metric For Genes Tech Group Holdings (HKG:8257)
Feb 23Is Genes Tech Group Holdings Company Limited's(HKG:8257) Recent Stock Performance Tethered To Its Strong Fundamentals?
Jan 19A Look At The Intrinsic Value Of Genes Tech Group Holdings Company Limited (HKG:8257)
Dec 16
Will Genes Tech Group Holdings (HKG:8257) Repeat Its Return Growth Of The Past?
Nov 24Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( NT$1.7B ) 8257 } overtreffen de korte termijn passiva ( NT$1.2B ).
Langlopende schulden: De kortetermijnactiva 8257 ( NT$1.7B ) overtreffen de langetermijnschulden ( NT$160.2M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 59.9% ) 8257 wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van 8257 is de afgelopen 5 jaar gedaald van 133.1% naar 74.1%.
Schuldendekking: De schuld van 8257 wordt niet goed gedekt door de operationele kasstroom ( 14.3% ).
Rentedekking: De rentebetalingen op de schuld van 8257 worden goed gedekt door EBIT ( 4.4 x dekking).